I carry around the quote “We cannot do everything, and there is a sense of liberation in realizing that,” by Archbishop Oscar Romero, in my bag, and resort to these words when I feel like I have to do more for the patient but can’t. These words carry much meaning in the life of an oncology fellow.
Hypnotherapy and gabapentin demonstrate efficacy in improving hot flashes. A definitive trial evaluating traditional interventions against CAM methods is feasible, but not without challenges. Further studies aimed at defining evidence-based recommendations for CAM are necessary.
Port devices are associated with a lower risk of complications, with no difference in cost, compared to PICC lines in patients with non-haematological malignancies receiving intravenous chemotherapy.
via Comparison of peripherally inserted central venous catheters (PICC) versus subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies – Online First – Springer.
Today, most children diagnosed with acute lymphocytic leukemia — the most common type — survive. But in the past, we oncologists significantly underestimated the cost of that survival.
A time-sovereignty framework offers health and support professionals a means of understanding carers’ varying needs and tailoring support services.
Statistically significant differences in the receipt of chemotherapy exist among elderly patients with SCLC. Chemotherapy is associated with a greater than 6-month improvement in median survival among elderly patients with SCLC, even in patients over the age of 80 years.
A study from UCLA’s Jonsson Comprehensive Cancer Center (JCCC) has found that head and neck cancer patients receiving radiation as part of their treatment were less likely to suffer unwanted side effects such as worsening of diet, need for a feeding tube, or narrowing of the throat passage if they complied with a set of prescribed swallowing exercises called a swallow preservation protocol (SPP) during therapy.
Diane Meier, MD, and the Director of CAPC (Center for Advancement of Palliative Care), challenges healthcare professions to view giving bad news as a medical procedure. By that, she means it’s something that takes extensive training, observation, and practice. It’s not something you send a junior resident in to do when the attending is occupied with other things.
In this rigorously conducted prospective study of SFPL changes post-RP, there was evidence of SFPL loss at two months, but not at six months postoperatively.
● PDE5i use moderated SFPL loss, with patients using PDE5i regularly demonstrating no length loss.
Patients with metastatic non-clear cell RCC from the SEER program, including those treated in the targeted therapy era, appear to derive a survival benefit from CN, an association which remained significant regardless of histologic subtype.
● This observation suggests that CN remains standard in advanced RCC patients deemed to be surgical candidates.